You searched for: guidance (Holländska - Engelska)

guidance energiebeheer
guidance power manager

proposal for new guidance ‘
proposal for new guidance'fixed

note for guidance on specifications:
note for guidance on specifications:

note for guidance on the clinical
core spc for human albumin adopted october 2000 note for guidance on the clinical investigation of human plasma derived factor viii and ix products released for consultation june 2000

note for guidance on carcinogenic potential
note for guidance on carcinogenic potential

note for guidance on dry powder inhalers
note for guidance on dry powder inhalers

guidance: geautomatiseerde bijstand voor de piloot.
guidance: automated assistance to the pilot.

update of note for guidance on carcinogenic potential
update of note for guidance on carcinogenic potential

zie technical notes for guidance on product evaluation.
see technical notes for guidance on product evaluation.

note for guidance on plasma-derived medicinal products
note for guidance on plasma-derived medicinal products

sccs notes of guidance, punt 4, blz. 66 en volgende.
sccs notes of guidance, para 4, p. 66 et seq.

sccs notes of guidance, punt 3-7.2, blz. 49.
sccs notes of guidance, para 3-7.2, p. 49.

ich q3c (m) maintenance document for guidance on impurities:
cpmp/ich/1940/00 ich q3c (m) maintenance document for guidance on impurities:

note for guidance on the conduct of pharmacovigilance for centrally authorised products
note for guidance on the conduct of pharmacovigilance for centrally authorised products

note for guidance on clinical investigation of medicinal products for treatment of pain
note for guidance on clinical investigation of medicinal products for treatment of pain

points to consider on xenogeneic cell therapy note for guidance on the production and
emea/ cpmp/ bwp/840/00

note for guidance on clinical investigation of medicinal products for treatment of nociceptive pain
note for guidance on the clinical investigation of medicinal products in the treatment of asthma

note for guidance on clinical investigation of medicinal products for the treatment of migraine.
points to consider on the evaluation of medicinal products for the treatment of irritable bowel syndrome

tests bij 50 mg/l/4h: zie guidance document 39 (8)
testing at 50 mg/l/4h: see guidance document 39 (8)

guidance paper on the acceptability of trade names for medicinal products processed through the centralised procedure
guidance paper on the acceptability of trade names for medicinal products processed through the centralised procedure